Covid vaccine, third dose to over 6 thousand Italians. “Pfizer safe between 5 and 11 years”

More than 6 thousand (6,803) Italians have received the third dose of the anti-covid vaccine (equal to 0.73% of the population subject to an additional dose / booster). Meanwhile, Pfizer-BioNTech say their serum is “safe for children between 5 and 11 years old”. Read also Anti-covid vaccine and third dose The new administration of anti-covid vaccine for the frail categories was launched yesterday. This is 3 million people at risk. In the next few days, the coronavirus emergency commissioner Figliuolo explains, the green light from the CTS should also arrive for health professionals, RSA and over 80. To receive the additional dose so far there have been 6,803 people (equal to 0.73% of the population subject to additional dose / booster. The total administration is 82,670,260: 44,356,849 (82.13% of the over 12 population) received at least one administration while 41,175,922 (76.24% of the over 12 population) received completed the vaccination cycle). Son: “Get informed, no one wants to force” “We are 41 million Italians vaccinated, we are about 76% of over 12. We await the CTS ok for the third dose to health workers, over 80 and guests of the RSA. To those who are suspicious of the vaccine, I say: get informed, no one wants to oblige “, said General Francesco Paolo Figliuolo, extraordinary emergency commissioner, expressed himself during the visit to the vaccination hub of Villorba, in Veneto. “We have seen an increase in vaccine bookings, we will see if this trend consolidates. I would like to appeal to those who are a little suspicious and wait: get informed, ask doctors and nurses, to those in hospitals who see the suffering for the covid. We have had over 130 thousand deaths from covid and there are people who bear the signs of long covid, I have friends who go up a flight of stairs and are out of breath. I tell you to inform yourselves and make a free choice, nobody wants to force “, added Figliuolo. “All the tools of democracy are fine. I am for the Constitution”, he replies to journalists who ask for an opinion on the hypothesized popular referendum against the mandatory Green Pass. “It is good for everyone to get information. Vaccinating is a civic and moral duty , as President Mattarella says. We must save those around us, we cannot be selfish. In this, our young people have given us a great lesson: in the 20-29 age group in a very short time we had the greatest number of adhesions, young people ran en masse to get vaccinated “, he continues. “Today the third doses start throughout Italy, we are talking about additional doses for the so-called immunocompromised, people with a compromised immune system”, highlights. Pfizer vaccine, “effective for children 5-11 years at lower doses” The Pfizer vaccine is effective and safe for children between 5 and 11 years old. Pfizer and BioNTech announced this based on the results of a phase 2/3 study showing for their Covid vaccine “a favorable safety profile and a robust response” in terms of neutralizing antibodies in children between the ages of 5 and 11 years, using a two-dose regimen of 10 micrograms (µg) 21 days apart. This is a lower dose than that (30 µg) used for people aged 12 years and older. The antibody responses in the participants who were given these quantities “were comparable to those recorded in a previous Pfizer-BioNTech study in people aged 16 to 25 years immunized with doses of 30 µg,” the two companies explain in a note. . “The 10 µg dose has been carefully selected as the preferred dose for safety, tolerability and immunogenicity in children aged 5-11 years.” Pfizer and BioNTech intend to present data on their vaccine “as soon as possible” anti-Covid in the 5-11 year range to the US Food and Drug Administration (Fda) and the European Medicines Agency Ema, but also to other regulatory bodies. On the one hand, they explain, “a request to the EMA is expected to update the EU conditional marketing authorization”. On the other hand, for the United States, companies plan to include the data in a short-term submission for Emergency Use Authorization (Eua), while they continue to accumulate safety and efficacy data needed to submit the request for full approval in this age group.